Patients matching those of the SIRIUS trial: de ... Clinical trial results.org. Among patients receiving sirolimus-eluting stents for treatment of single, de ...
SESAMI Trial Sirolimus Stent vs. Bare Stent in Acute Myocardial Infarction Trial Presented at The EuroPCR meeting Paris, France May 2006 Presented by Dr. Maurizio ...
Bern-Rotterdam Registry Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large ...
The Multicenter International LAM Efficacy of Sirolimus Trial (MILES Trial) Frank McCormack, M.D. Scientific Director, The LAM Foundation Professor and Director ...
Background. Restenosis occurring within a drug-eluting stent (DES) is a rare event. Optimal treatment strategies have not been identified and options range from ...
The Multicenter International LAM Efficacy of Sirolimus Trial ... CAT scan. and ... CAT scans of the chest are done at the beginning, middle and the end. MILES ...
Responses to the mTOR Inhibitor Sirolimus in Patients with Malignant PEComa Andrew Wagner, Robert Maki, Cristina Antonescu, Christopher Fletcher, Jeffrey Morgan
1012 patients with symptomatic coronary artery disease, presence of at least one ... Among patients with coronary artery disease, treatment with the sirolimus ...
Randomised comparison of a novel, ultrathin strut biodegradable polymer sirolimus-eluting stent with a durable polymer everolimus-eluting stent for percutaneous ...
Indications: Prophylaxis of organ rejection in patients aged 13 years or older ... renal transplant patient on sirolimus, tacrolimus, atorvastatin, ferrous sulfate ...
LONG-DES II Trial Randomized Comparison of the Efficacy of Sirolimus-Eluting Stent Versus Paclitaxel-Eluting Stent in the Treatment of Long Native Coronary Lesions:
Title: The Detrimental Impact of Chronic Renal Insufficiency Author: jzuccardy Last modified by: Robert Byrne Created Date: 9/24/2010 10:16:56 AM Document ...
Biolimus-Eluting Stent With Biodegradable. Polymer Versus Sirolimus-Eluting ... at a concentration of 15.6 g/mm into a biodegradable polymer, polylactic ...
Evaluation by OCT of Neointimal Coverage of Sirolimus-Eluting Stent Three Months ... seem to float into the lumen compared with the extra-stent lumen (arrowheads) ...
( B) Length between surfaces of the neointima and each stent strut (NIH thickness) ... ( B) A strut is surrounded by an intracoronary structure with an irregular ...
Randomized Comparison of Percutaneous Coronary Intervention with Sirolimus-Eluting Stents versus Coronary Artery Bypass Grafting in Unprotected Left Main Stem Stenosis
... cared for by the Immunology Service at the Children's Hospital ... appreciative of the support of the Leonard Davis Institute of Health Economics and ...
Clinical Outcomes in Diabetic Patients With Multivessel ... Left circumflex. 39. 42. Left anterior descending. 6. 4. Left main. 0.26. Target lesion location ...
Bern-Rotterdam Registry Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large ...
Title: Folie 1 Author: sysman Last modified by: psavuser Created Date: 8/16/2010 7:09:41 AM Document presentation format: On-screen Show (4:3) Other titles
Title: RRISC IVUS Subject: PCI in SVG Author: Agostoni Created Date: 1/1/1601 12:00:00 AM Document presentation format: Presentazione su schermo Company
Infrapopliteal Sirolimus-Eluting Versus Bare Metal Stents for Critical Limb Ischemia: ... Compared to bare metal stents, application of sirolimus-eluting ...
Medical or pharmacokinetic explanations for such observations should be sought and discussed As ... Flecainide, Lithium, Phenytoin, Sirolimus, Tacrolimus ...
Title: Neointimal Hyperplasia and Peri-stent Remodeling after Sirolimus-eluting or Paclitaxel-eluting Stent Implantation in Diabetic Patients A Randomised ...
PROTECT Stent thrombosis and major clinical events at 3 years after zotarolimus-eluting or sirolimus-eluting coronary stent implantation : a randomised multicentre ...
Maintenance of Long-Term Clinical Benefit with Sirolimus-Eluting Stents in Patients with ST-Segment Elevation Myocardial Infarction: Three-year results